Publications by authors named "Roberto Freilone"

Claim this Profile
O
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensus.
Stefano Luminari, Annalisa Chiappella, Alice Di Rocco, Luca Arcaini, Roberto Freilone

Cytotherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, Andrea Evangelista, Francesca Maria Quaglia, Roberto Freilone

Lancet Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to CAR T-Cells and How to Overcome Them.
Luca Legato, Matteo Bisio, Filippo Fasano, Corrado Benevolo Savelli, Carolina Secreto, Roberto Freilone

Methods Protoc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus.
Valentina Giai, Tiziana Rosso, Fausto Castagnetti, Patrizia Pregno, Massimiliano Bonifacio, Roberto Freilone

Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.
Rexhep Durmo, Stephane Chauvie, Federico Fallanca, Fabrizio Bergesio, Antonio Pinto, Roberto Freilone

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Marco Cerrano, Roberto Freilone

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Efficacy and toxicity of brexucabtagene autoleucel in the treatment of high-risk mantle cell lymphoma: description of a clinical case].
Mattia Novo, Corrado Benevolo Savelli, Barbara Botto, Roberto Freilone

Recenti Prog Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial.
Giulia Benevolo, Daniela Drandi, Nicoletta Villivà, Anna Castiglione, Federico Monaco, Roberto Freilone

Br J Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific Antibodies for Lymphoid Malignancy Treatment.
Matteo Bisio, Luca Legato, Filippo Fasano, Corrado Benevolo Savelli, Carola Boccomini, Roberto Freilone

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia: Results of a Single-Center Study.
Davide Stella, Jessica Gill, Roberto Passera, Sofia Zompi, Chiara Maria Dellacasa, Roberto Freilone

Hematol Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Differentiation Syndrome with Sudden Vision Loss in Acute Promyelocytic Leukemia Treated with ATRA plus ATO: a Clinical Case.
Eleonora Boscaro, Marco Cerrano, Tommaso Tibaldi, Carlotta Zavatto, Michele Reibaldi, Roberto Freilone

Mediterr J Hematol Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study.
Irene Dogliotti, Veronica Peri, Michele Clerico, Francesco Vassallo, Davide Musto, Roberto Freilone

Cancer Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice.
Corrado Benevolo Savelli, Matteo Bisio, Luca Legato, Filippo Fasano, Elisa Santambrogio, Roberto Freilone

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria.
Sergio Di Matteo, Roberto Freilone, Giacomo Matteo Bruno, Rosario Notaro, Sabrin Moumene

Clinicoecon Outcomes Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience.
Irene Urbino, Carolina Secreto, Vincenzo Apolito, Matteo Olivi, Giulia Arrigo, Roberto Freilone

Leuk Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions.
Corrado Benevolo Savelli, Michele Clerico, Barbara Botto, Carolina Secreto, Federica Cavallo, Roberto Freilone

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Vincenzo Apolito, Giulia Arrigo, Loic Vasseur, Matteo Olivi, Silvia Perrone, Roberto Freilone

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors.
Eleonora Boscaro, Irene Urbino, Federica Maria Catania, Giulia Arrigo, Carolina Secreto, Roberto Freilone

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Chiara Frairia, Barbara Nicolino, Carolina Secreto, Emanuela Messa, Giulia Arrigo, Roberto Freilone

Eur J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges.
Matteo Olivi, Federica Di Biase, Giuseppe Lanzarone, Giulia Arrigo, Federica Martella, Roberto Freilone

Curr Treat Options Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study.
Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Roberto Freilone

Mediterr J Hematol Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial.
Paola Maria Manzini, Giovannino Ciccone, Francesco Giuseppe De Rosa, Rossana Cavallo, Valeria Ghisetti, Roberto Freilone

BMC Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature.
Giulia Arrigo, Stefano D'Ardìa, Ernesta Audisio, Marco Cerrano, Roberto Freilone

Acta Haematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Federica Martella, Marco Cerrano, Daniela Di Cuonzo, Carolina Secreto, Matteo Olivi, Roberto Freilone

Ann Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features.
Valentina Giai, Carolina Secreto, Roberto Freilone, Patrizia Pregno

Medicina (Kaunas)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis